News
CODX
1.130
+2.71%
0.030
Weekly Report: what happened at CODX last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at CODX last week (0708-0712)?
Weekly Report · 07/15 11:49
Weekly Report: what happened at CODX last week (0701-0705)?
Weekly Report · 07/08 11:51
Co-Diagnostics Expands Vector Control Customer Base To 25 Customers Across 15 U.S. States, Following An Installation In Nevada Next Week
Use of Co-Diagnostics' vector control technology will expand to the 15th U.S. State following an installation in Nevada next week. Co-Dx's Vector Smart tests are used in environmental surveillance of mosquito pools for mosquito-borne illnesses like West Nile virus.
Benzinga · 07/02 13:33
Weekly Report: what happened at CODX last week (0624-0628)?
Weekly Report · 07/01 11:52
Weekly Report: what happened at CODX last week (0617-0621)?
Weekly Report · 06/24 12:01
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. Invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21. Co-Dx is a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests.
Barchart · 06/18 12:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Co-Diagnostics (CODX)
TipRanks · 06/17 15:10
Co-Diagnostics Price Target Maintained With a $2.00/Share by HC Wainwright & Co.
Dow Jones · 06/17 15:06
HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $2 Price Target
Benzinga · 06/17 14:56
Weekly Report: what happened at CODX last week (0610-0614)?
Weekly Report · 06/17 11:50
CO-DIAGNOSTICS, INC. SUBMITS FIRST FDA 510(K) APPLICATION FOR CO-DX PCR PRO PLATFORM
Reuters · 06/14 13:30
Co-Diagnostics Inc: Current report
Press release · 06/14 12:13
12 Health Care Stocks Moving In Monday's Pre-Market Session
Calidi Biotherapeutics shares rose 29.7% to $0.25 during Monday's pre-market session. Entero Therapeutics (NASDAQ:ENTO) shares rose 22.41% during the session. Co-Diagnostics stock moved upwards by 14.07%. Sunshine Biopharma and Skye Bioscience were among the losers.
Benzinga · 06/10 12:06
Weekly Report: what happened at CODX last week (0603-0607)?
Weekly Report · 06/10 11:53
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
G-III Apparel Group shares dipped 13.4% to $27.12 on Thursday. The company reported worse-than-expected quarterly sales results. Virax Biolabs Group Limited and American Oncology Network were among the stocks moving in the mid-day session.
Benzinga · 06/06 17:39
12 Health Care Stocks Moving In Thursday's Intraday Session
Virax Biolabs Group (NASDAQ:VRAX) shares rose 88.8% to $2.02 during Thursday's regular session. American Oncology Network stock rose 32.96% during the session. Ventyx Biosciences stock fell 37.9% in the same session.
Benzinga · 06/06 16:31
Weekly Report: what happened at CODX last week (0527-0531)?
Weekly Report · 06/03 11:56
Weekly Report: what happened at CODX last week (0520-0524)?
Weekly Report · 05/27 12:02
Weekly Report: what happened at CODX last week (0513-0517)?
Weekly Report · 05/20 11:53
More
Webull provides a variety of real-time CODX stock news. You can receive the latest news about Co-Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CODX
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.